/Investor DB

S32 — 2022 Investments

7 investments dated 2022 · listed companies and verified rows first · show all

BigHat Biosciencesbighatbio.comin𝕏Series B · Jul 2022 · $75M

Big Hat Bio develops therapeutics under development across multiple programs.

AI & Machine LearningBiotechDeep TechSan Francisco, US

Peyton Greenside(Founder)inMark DePristo(Founder)inMark DePristo Peyton Greenside(Founder)Theresa Tribble(Founder)

BoardFrancisco Gimenez(Director)inSteve Kafka(Director)

Co-investors8VCAndreessen HorowitzBOLD LongevityFlucas VenturesGaingelsGRIDS Capital+12 more

Inworld AIinworld.aiin𝕏Series A · Aug 2022 · $50M

Inworld AI provides a full-duplex audio streaming platform that enables real-time conversational AI interactions with intelligent turn-taking, function calling, and multi-model routing capabilities for developers building conversational applications.

AI & Machine LearningDeveloper ToolsMountain View, US

Ilya Gelfenbeyn(Founder)inKylan Gibbs(Founder)inMichael Ermolenko(Founder)in

Co-investorsA-Force VenturesBitkraft Esports VenturesBrave CapitalCRV (Charles River Ventures)Dentsu VenturesDisney Accelerator+15 more

Metaphysicmetaphysic.aiSeed · Jan 2022 · $8MAcquired

Metaphysic was a London-based generative AI studio founded in 2021 that developed deepfake and digital de-aging technology used in Hollywood films like "Here," and licensed likeness tools to brands and individuals.

London

Kevin Ume(Executive Officer, Director, Promoter)Christopher Ume(Executive Officer, Director, Promoter)Thomas Graham(Founder)Chris Umé(Founder)Kevin Umé(Founder)

Co-investorsCosmic Venture PartnersManta Ray VenturesTectonic Ventures

Nucleainucleai.aiSeries B · Mar 2022 · $33M

Avi Veidman(Founder)Eliron Amir(Founder)Lotan Chorev(Founder)

Co-investorsM VenturesSanofi VenturesSAV (Scale Asia Ventures)Vertex Ventures IsraelDebiopharm Innovation FundGrove Ventures+1 more

Satellite Biosatellite.bioSeries A · Mar 2022 · $82M

Satellite Bio develops an off-the-shelf cell therapy that delivers functional liver cells (hepatocytes) into the body, where they engraft to restore liver function.

BiotechHealthtechCambridge, US

Christopher Chen(Director, Promoter)inThomas Lowery(Executive Officer)

BoardEllie McGuire(Director)Ling Wong(Director)Sujata Bhatia(Director)William Young(Director)

Co-investorsAlumni VenturesaMoonCatalio Capital Management, LPLightspeed Venture PartnersHighbury HoldingsPolaris Partners

Stairwellstairwell.cominSeries B · Oct 2022 · $45M

Stairwell provides cybersecurity threat intelligence solutions to help teams identify and address security threats.

Cybersecurity

Mike Wiacek(Founder)

Co-investorsAccelBallistic VenturesGradient VenturesIn-Q-TelSequoia CapitalEric Schmidt+4 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Alpha Source

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.